ENTITY
Celltrion

Celltrion (068270 KP)

25
Analysis
Health Care • South Korea
Celltrion, Inc. produces and sells biosimilar products, as well as consignment processing services for other businesses.
more
bearish•Celltrion Inc
•19 Oct 2016 11:06

The Chickens Are Ready to Roost

Several recent developments confirm our thesis that Inflectra's US sales in 2017 will fall far short of management's 2017 forecast. First, Pfizer's...

Share
bullish•Celltrion Inc
•19 Oct 2016 03:26

Teva May Buy Celltrion - Implications for Celltrion & Celltrion Healthcare

How should we interpret Teva's potential acquisition of Celltrion? Is this for real? Well, Teva may still be very interested in acquiring Celltrion...

Logo
345 Views
Share
•14 Oct 2016 14:04

Internet of Things Will Change the World (Part 7) - 2016 IoT Exhibition & Conference in Seoul

We attended the 2016 IoT Exhibition & International Conference (Seoul) yesterday, which is the largest one for the IoT sector in Korea. We...

Logo
699 Views
Share
•11 Oct 2016 01:22

Important Regulatory Changes for IPOs on the KOSDAQ Exchange

There are some important regulatory changes that are coming to the IPOs market for companies listing on the KOSDAQ exchange in Korea. Although the...

Logo
374 Views
Share
bearish•Samsung Biologics
•05 Oct 2016 12:01

Samsung BioLogics IPO Part 3 - Valuation

Samsung BioLogics has just filed an IPO report. I will summarize Samsung BioLogics IPO report in the following three parts:Part 1 - IPO...

Logo
450 Views
Share
x